Evidence map›Paper›PMID 41218134›Full record

ArticleAntimicrobial agents and chemotherapy2025

First nationwide survey on

Neisa Alvarado-Orosco, Maria A Gomis-Font, Miquel A Sastre-Femenia, Silvia Ribera Ortiz, Maritza Miranda Arce, María Elena Araúz Barba, María Del Rosario Navia Durán, Sandra Grisel Vargas Nattez, Gabriela Cabellos Astorga, Paola Janeth Villarroel Rodriguez and 11 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Neisa Alvarado-Orosco *UF of Bacteriology, National Center for Tropical Diseases (CENETROP), Santa Cruz de la Sierra, Bolivia.
Maria A Gomis-Font *Department of Microbiology, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Islas Baleares (IdISBa), CIBERINFEC, Palma, Spain.ORCID 0000-0001-6042-5674
Miquel A Sastre-FemeniaDepartment of Microbiology, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Islas Baleares (IdISBa), CIBERINFEC, Palma, Spain.
Silvia Ribera OrtizMicrobiology Laboratory, Hospital San Juan de Dios, Santa Cruz de la Sierra, Bolivia.
Maritza Miranda ArceDepartment of Bacteriology, Hospital Universitario Japonés, Santa Cruz de la Sierra, Bolivia.
María Elena Araúz BarbaMicrobiology Laboratory, Hospital Obrero N. 3, Santa Cruz de la Sierra, Bolivia.
María Del Rosario Navia DuránMicrobiology, Hospital Santa Bárbara, Sucre, Bolivia.
Sandra Grisel Vargas NattezMicrobiology Laboratory, Hospital del Norte, El Alto, La Paz, Bolivia.
Gabriela Cabellos AstorgaMicrobiology Laboratory, Hospital Clinico Viedma, Cochabamba, Bolivia.
Paola Janeth Villarroel RodriguezMicrobiology, Hospital Elizabeth Seton-Caja Petrolera de Salud, Cochabamba, Bolivia.
Damariz Daniela Almaraz RocaDepartment of Bacteriology, Instituto Gastroenterológico Boliviano-Japonés, Cochabamba, Bolivia.
Marleni Castillo CruzMicrobiology Laboratory, Hospital Daniel Bracamontes, Potosí, Bolivia.
Juan Pablo Chambi CondoriMicrobiology Laboratory, Hospital de Tercer Nivel, Montero, Santa Cruz de la Sierra, Bolivia.
Pedro Quevedo RiberaDepartment of Bacteriology, Hospital Municipal Bajío del Oriente, Santa Cruz de la Sierra, Bolivia.
Suan Mishelly Patino GarcíaMicrobiology Laboratory, Hospital Municipal Villa Primero de Mayo, Santa Cruz de la Sierra, Bolivia.
Yenny Contreras OtaloraMicrobiology Laboratory, Hospital Municipal Francés, Santa Cruz de la Sierra, Bolivia.
Flor María Rosales ReaDepartment of Bacteriology, Hospital Municipal Alfonso Gumucio Reyes, Montero, Santa Cruz de la Sierra, Bolivia.
Claudia Milena Portugal GutiérrezLaboratory HODE Materno Infantil-CNS, La Paz, Bolivia.
Marisol Sánchez SerranoDepartment of Bacteriology, Hospital Caja de Salud Caminos, Santa Cruz de la Sierra, Bolivia.
Carla López-CausapéDepartment of Microbiology, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Islas Baleares (IdISBa), CIBERINFEC, Palma, Spain.ORCID 0000-0003-2228-2005
Antonio OliverDepartment of Microbiology, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Islas Baleares (IdISBa), CIBERINFEC, Palma, Spain.ORCID 0000-0001-9327-1894

Funding

Ministerio de Ciencia e Innovación (MCI) de España y el programa NextGenerationEU CB21/13/00099Ministerio de Ciencia e Innovación (MCI) de España y el programa NextGenerationEU PI24/00010Ministerio de Ciencia e Innovación (MCI) de España y el programa NextGenerationEU PMP22/00092National Center for Tropical Diseases (CENETROP)
6 · The paper itself

Abstract

Information on the molecular epidemiology of

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialPseudomonas aeruginosaPseudomonas InfectionsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesBoliviaCeftazidimeCephalosporinsColistinHumansImipenemMicrobial Sensitivity TestsMolecular EpidemiologyTazobactamAnti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCeftazidimeceftolozane, tazobactam drug combinationCephalosporinsColistinImipenemTazobactamantimicrobial resistancegenomic epidemiologyPseudomonas aeruginosa

Identifiers

PMID41218134
PMCPMC12691617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.